A Risk Model to Predict the Delivery of Adjuvant Chemotherapy Following Lung Resection in Patients With Pathologically Positive Lymph Nodes

To investigate factors associated with the ability to receive adjuvant chemotherapy in patients with pathological N1 and N2 stage after anatomic lung resections for non-small cell lung cancer (NSCLC). Multicenter retrospective analysis on 707 consecutive patients found pathologic N1 (pN1) or N2 (pN2...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Seminars in thoracic and cardiovascular surgery 2023, Vol.35 (2), p.387-398
Hauptverfasser:	Patella, Miriam, Brunelli, Alessandro, Adams, Laura, Cafarotti, Stefano, Costardi, Lorena, De Leyn, Paul, Decaluwé, Herbert, Franks, Kevin N., Fuentes, Marta, Jimenez, Marcelo F., Karri, Sunanda, Moons, Johnny, Novellis, Pierluigi, Ruffini, Enrico, Veronesi, Giulia, Voulaz, Emanuele, Shargall, Yaron
Format:	Artikel
Sprache:	eng
Schlagworte:	Adjuvant chemotherapy Carcinoma, Non-Small-Cell Lung - surgery Chemotherapy, Adjuvant Humans Infant, Newborn Lung - pathology Lung - surgery Lung Neoplasms - pathology Lung Neoplasms - surgery Lymph Nodes - pathology Lymph Nodes - surgery Neoplasm Staging Node positive lung cancer Non-small cell lung cancer Pneumonectomy - adverse effects Retrospective Studies Surgical treatment Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!